2022年11月29日

分享这篇文章提供的新闻Americord与Veritas遗传学,基因组筛选LetsGetChecked公司和领导者,提供新生儿和产妇全基因组筛查。myNewborn和myGenome发行授权人优先,保护他们的健康和他们的孩子的健康状况比以往任何时候都多。”——彼得·弗利纽约,纽约,美国,11月29日,2022 / EINPresswire.com——Americord注册®与Veritas遗传学、LetsGetChecked拥有公司和全球领先的基因筛选、开发和提供新生儿和产妇全基因组筛查Americord家庭。Americord专门提供生物对怀孕的母亲和家庭服务。套health-focused服务包括脐带血,脊髓组织,胎盘组织,外来体银行业。通过添加基因组服务这个列表,Americord旨在提供至关重要的健康知识更好地装备未来的家庭。“我们骄傲与遗传学和LetsGetChecked Veritas合作,分享我们的承诺帮助人们活得更长,更健康的生活,”马丁Smithmyer说,首席执行官Americord注册表。“我们希望我们的家庭访问广泛的医学测试,这样他们就可以做出明智的决定对他们的健康。雷竞技 raybet“myGenome,下令由卫生保健提供者和基因筛查服务可用于成年人,旨在检测650变量医疗条件和为个人提供见解遗传条件在多个类别的风险包括癌症、心血管疾病和免疫紊乱。myGenome结果返回到命令提供者和能给准妈妈见解对他们可能携带或遗传性疾病传给他们的孩子。雷竞技 raybet myNewborn offers screening for more than 390 genetic conditions that onset during early childhood and require guidance for timely and effective interventions. The test is ordered by a healthcare professional and is available for healthy or asymptomatic newborns and children in the first year of life. “Our myNewborn and myGenome offerings empower people to prioritize and protect their health and the health of their children more than ever before,” said Peter Foley, Founder and CEO of LetsGetChecked. “By partnering with Americord, we are able to personalize healthcare at a crucial stage for a child and turn comprehensive genetic insights into practical recommendations and lifestyle changes, guided by clinical experts.” “Obtaining a molecular diagnosis in a timely manner enables patients to have appropriate and prompt access to management, crucial in early childhood and for adult onset conditions where early intervention improves outcomes,” said Dr. Avni Santani, Chief Medical Officer of Veritas Genetics, a LetsGetChecked company. “We have seen the power of periodically interrogating individuals’ genetic data for new insights[1] and our genome and exome based screening programs create the opportunity to do exactly that.” About Americord Americord is the industry leader in preserving stem cells from umbilical cord blood, umbilical cord tissue, and the amniotic membrane of the placenta, allowing parents to help keep their families healthy for life by preserving cells for future use. Americord also develops therapeutics from these tissues to improve clinical outcomes for the general population. Americord is registered with the FDA and is committed to operating within the highest ethical and regulatory standards. Americord acknowledges that exosomes are not FDA-approved for use in treatments or products. Americord does not claim exosomes have any current therapeutic benefit. The client understands that they bank their child’s exosomes for use in clinical trials and research which may provide utility in the future. About Veritas Genetics Veritas Genetics, owned by LetsGetChecked, is an industry leader in making testing accessible and frictionless. Founded by genomics leaders from Harvard Medical School and MIT, including Dr. George Church, the company has received multiple awards, including CNBC’s Disruptor50, MIT Technology Review’s 50 Smartest Companies, and Fast Company’s Most Innovative Companies. About LetsGetChecked LetsGetChecked is a global healthcare solutions company that provides the tools to manage health from home through access to testing, genetic sequencing and insights, virtual consultations, and medication delivery for a wide range of health and wellness conditions. LetsGetChecked’s end-to-end model includes manufacturing, logistics, lab analysis, clinician support, and prescription fulfillment. Founded in 2015, the company empowers people with accessible health information and care to live longer, happier lives. Casey Stoneman Roberson